RE:RE:RE:RE:RE:RE:RE:RE:RE:NewsI have been in MT for a while (I can ride my bike ot their HQ... it's SP may overtake CGC's ... may not but at least be up there. Look at its capital structure ... shares outstanding and again as fully diluted. Really no cheap warrants etc. PLUS if the current patient growth trends continue it could overtake CGC in number of patients (CGC of course is Tweed + Bedrcoan combined meaning MT has more patients than either one of those on their own). Advertising is illegal of course and MT is the only LP with a Hemp line so they can advertise too! Molson Amplitheatre naming rights and sole source contract for their product line (Hemp line of course) and 2017 is Canada's 150th ... Amplitheatre will be jumping all spring and summer and well into the fall. Sad when you have to talk about another company in order to post positive here. Hey, EMH got their oils licence last night! Cheers fringelife wrote: Depends on whether it's a big enough loss or not I guess. This one still has the potential to do something, but they didn't show that potential recently with how they handled the consolidation. I might get shocked again though and find myself missing out.
I seen in another thread that you have a position with Mettrum, I wish I did too now lol. Most of my stocks were bought under a dollar, except for CGC and APH. I wanted a third over a dollar, but instead chose to split them up between companies like Supreme, Organigram and a bunch of smaller ones. I never thought MT was a bad play, just had to make tough choices leaving that one out. Now I"m regretting it as I have a practice money account with MT and it's now up 40%. I hate seeing fake money doing so well lol.
I swear it's always the ones that I least suspect. I knew MT was gonna do well, it just surprised me how well it has done.